Use our Project or Categories filter to narrow down your news search.

Reset

Is Aging a Disease You Can Reverse? A Look at the Science Behind the Longevity Movement

Vogue |
September 2020
Press Release

“Aging can be considered a disease—one that can be targeted, treated, and perhaps even reversed…The new Preventive Genomics Clinic at Brigham and Women’s Hospital in Boston is the first academic clinic in the country to offer comprehensive DNA sequencing and interpretation of nearly 6,000 disease-associated genes.”    

Genomic sequencing to screen newborns raises more false alarms than routine blood tests

STAT |
August 2020
Press

In this study led by UCSF researchers, exome sequencing was found to produce more false positives and false negatives for inherited metabolic disorders than the standard blood testing conducted in newborns. G2P’s Dr. Robert Green, co-leader of the BabySeq Project, speaks to the possibility “that the most comprehensive screening for newborns will be some combination … Continued

G2P Newsletter July 2020

July 2020
G2P News

Since beginning to work remotely at the start of COVID-19, our team has found ways to build and maintain momentum in identifying new research projects, working on new grant applications and publishing prior work. Over the past few months, G2P faculty have attended numerous virtual conferences, been featured in the news and media, and contributed … Continued

Hospital records hold valuable Covid-19 data. Making it usable is time-consuming work

STAT |
May 2020
Press

To help scientists around the globe study Covid-19, researchers in Boston have shared genetic and other clinical data from thousands of patients with an international consortium. That data includes information from dozens of people with Covid-19, who had donated blood samples and opened up their medical records before the pandemic.

Genetic counselors and the fight for medicare recognition

Medium |
May 2020
G2P Blog

Elizabeth Fieg, MS, LCGC discusses the importance and implication of the H.R. 3235-The Access to Genetic Counselor Service Act that would authorize and recognize appropriately credentialed genetic counselors as reimbursable providers under Medicare.

Geneticist says DNA testing should be part of everyday healthcare

CNBC |
May 2020
Press, Video

Dr. Robert Green is the director of the Preventive Genomics Clinic at Brigham and Women’s Hospital in Boston. He believes that DNA testing combined with proper counseling and medical follow-up would be a critical element of a healthcare system that can prevent illness.

Coronavirus: Genes may explain why some face greater danger than others

Fox News |
April 2020
Press

“While healthy young people as a group are less likely to have severe symptoms with COVID, they have to understand that some of them will become very ill and will even die from this infection,” Dr. Robert Green said. “No one should assume youth makes them invulnerable.”

Of Known Significance

Clinical Omics |
March 2020
Press

An exclusive Clinical OMICs conversation with the director of Genomes2People, Robert Green, M.D., MPH

All in for All of Us

Brigham Clinical and Research News |
March 2020
Press

Through national research efforts like the All of Us Research Program, Brigham investigators and their collaborators are making genomic research more meaningful, equitable and impactful for all patients at the Brigham and around the world.

G2P Newsletter February 2020

February 2020
G2P News

In our winter edition newsletter, we have recapped all the incredible work that the G2P team has been doing since the fall. The Preventive Genomics Clinic has now seen 100+ patients. G2P work has been cited in numerous news & media outlets, and our collaborators at Genomes2Veterans have published spectacular data on implementation of precision … Continued

Econogenomics: The economics of genomic testing for health

Medium |
January 2020
G2P Blog

“The cost of sequencing itself is already comparable to a lot of other diagnostic tests regularly used in medicine,” Kurt Christensen, PhD said. Besides: “What really moves the needle on cost effectiveness isn’t the costs — it’s the benefits.”

Reset your DNA to slow the clock

Neo Life |
December 2019
Press

A new epigenetic test that tracks molecular aging claims to show you how to stay biologically young. However, Robert Green says “epigenetic marks in apparently healthy people can tell them meaningful things about their health status is an overreach.”

Apple is offering free genetic tests to all its Silicon Valley employees

CNBC |
December 2019
Press

“It’s really exciting that to see companies move to preserve health, rather than just treating patients when they’re ill,” said Dr. Robert Green, a medical geneticist at Harvard Medical School and a co-founder of a genetics company called Genome Medical.

23 and baby

Nature |
December 2019
Press

We now have the ability to screen for thousands of genetic diseases in newborns. That may not always be the healthy thing to do.

Addressing barriers to expanding genetic counseling

Modern Health Care |
November 2019
Press

Genetic counselors are becoming a bigger part of the healthcare continuum as population health management seeks to more quickly screen for, assess and prevent illness. Read on as genetic counselors in the field, including our own, Carrie Blout, address some of the barriers in genetic counseling.

China’s genetics giant wants to tailor medicine to your DNA

Bloomberg |
November 2019
Press

BGI is racing toward a world where your DNA informs your medical decisions—and maybe some of your personal ones. Bloomberg asks Dr. Robert Green on his thoughts regarding the medical advances in genomics in China and how they compare to those in the US.

G2P Newsletter October 2019

October 2019
G2P News

This Fall, G2P launched the Brigham Preventive Genomics Clinic, the first ever to offer comprehensive sequencing to healthy adults and children. We also hosted the PopSeq Inaugural Retreat in Boston to kick-off the first ever study to return unanticipated genetic findings to African Americans and examine rare diseases in population-based cohorts. Check out the new … Continued

Preventive Genomics Brochure

October 2019
Press

Please view our online brochure if you are interested in learning more about the Preventive Genomics Clinic at Brigham & Women’s Hospital

Frequently Asked Questions

October 2019
Press

Want more information on the Preventive Genomics Clinic? Check out answers to our most frequently asked questions.

Is preventive genomics elitist?

Medium |
October 2019
G2P Blog

The ultimate aim of our Genomes2People Research Program is to contribute to the transformation of medicine from reactive to proactive, from treatment-oriented to preventive. We are trying to help build the evidence base that will justify societal decision to make these technologies and services accessible to anyone who wants them, regardless of means, education or … Continued

Brigham and Women’s Hospital opens preventive genomics clinic

Genome Web |
August 2019
Press

“Preventive genomics is not yet recommended as standard of care,” Robert Green, director of the Preventive Genomics Clinic, said in a statement. “But for over two decades, our NIH-funded, randomized trials in translational genomics have generated consistent evidence that there are more potential medical benefits and fewer risks than previously considered. It is time for … Continued

NHGRI Announces Six Inaugural Genomic Innovator Awards

National Human Genome Research Institute |
August 2019
Press

Dr. Jason Vassey was announced as one of six recipients for the Genomic Innovator supporting early career investigators researching genome biology, genomic medicine, technology development and societal implications of genomic advances.

FDA stepping up actions against PGx testing, forcing some labs to stop reporting drug information

Genome Web |
August 2019
Press

Researchers led by Robert Green at Brigham and Women’s Hospital looked at whether consumers getting direct-to-consumer genetic testing were using PGx tests to change treatment decisions. Although this study relied on self-reported data from participants, it suggests that less than 1 percent could have made unsupervised medication changes based on their genetic test results.

Iman Abdulmajid receives Franca Sozzani Award

August 2019
Press Release

Disruptive philanthropist, activist and fashion innovator Iman Abdulmajid will receive the award at a dinner on the eve of the 76th Venice Film Festival.